Combined modality therapy for limited-disease small cell lung cancer
β Scribed by Luis Raez; Michael Samuels; Rogerio Lilenbaum
- Book ID
- 107531899
- Publisher
- Springer
- Year
- 2005
- Tongue
- English
- Weight
- 188 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1527-2729
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND A Phase III trial was conducted by the North Central Cancer Treatment Group to determine whether chemotherapy (etoposide and cisplatin) plus either twiceβdaily radiotherapy (BIDRT) or onceβdaily radiotherapy (QDRT) resulted in a better outcome for patients with limitedβst
Multi-modality treatment consisting of cisplatin, VP-16, and 5-fluorouracil chemotherapy given concomitantly with external beam radiation was used to treat 64 patients with locally advanced Stage I11 non-small cell lung carcinoma. This regimen was used in a preoperative fashion for four cycles in pa
Between 1975 and 1980, 101 patients with inoperable Stage IIIMO non-small cell lung carcinoma were entered into combined radiotherapy and chemotherapy trials at Michael Reese Hospital and University of Chicago Hospital. Sixty-four percent of the patients responded. Median survival for all patients w